0001140361-23-044843.txt : 20230921
0001140361-23-044843.hdr.sgml : 20230921
20230921213013
ACCESSION NUMBER: 0001140361-23-044843
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20230921
DATE AS OF CHANGE: 20230921
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Roivant Sciences Ltd.
CENTRAL INDEX KEY: 0001635088
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981173944
STATE OF INCORPORATION: D0
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-40782
FILM NUMBER: 231270121
BUSINESS ADDRESS:
STREET 1: CLARENDON HOUSE, 2 CHURCH STREET
CITY: HAMILTON HM11
STATE: D0
ZIP: HM11
BUSINESS PHONE: 441-295-5950
MAIL ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kumar Rakhi
CENTRAL INDEX KEY: 0001856296
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O NEUROPACE INC
STREET 2: 455 N BERNARDO AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
144
1
primary_doc.xml
144
0001856296
XXXXXXXX
LIVE
0001635088
Roivant Sciences Ltd.
001-40782
7th Floor
50 Broadway
London
X0
SW1H 0DB
44 207 400 3347
Kumar Rakhi
Chief Accounting Officer
Common shares, $0.0000000341740141 par value per share (???Common Shares???)
E*TRADE FINANCIAL CORPORATION
3 EDISON DRIVE
ALPHARETTA
GA
30005
2671
27591.43
771742197
09/21/2023
Nasdaq
Common Shares
09/20/2023
Restricted Stock Units granted under the Roivant Sciences Ltd. Amended and Restated 2015 Equity Incentive Plan
Roivant Sciences Ltd.
N
2671
09/20/2023
N/A
N
Rakhi Kumar
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
06/22/2023
1357
13583.57
Rakhi Kumar
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
07/14/2023
535
6420
Rakhi Kumar
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
07/18/2023
100
1200
Rakhi Kumar
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
07/24/2023
1393
15309.07
Rakhi Kumar
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
08/01/2023
336
4032
Rakhi Kumar
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
08/03/2023
3681
44172
Rakhi Kumar
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
08/22/2023
1378
14923.74
Rakhi Kumar
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
09/05/2023
1724
20688
Rakhi Kumar
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
09/08/2023
99350
1210083
The securities included in Table I represent a maximum number of shares that may be sold to cover the reporting person's tax obligations when restricted stock units belonging to the reporting person are settled. The securities reported in Table I do not represent discretionary trades by the reporting person, and will be sold, or were sold, as applicable, for the limited purpose of satisfying tax withholding obligations. The securities included in Table II sold on June 22, 2023, July 23, 2023 and August 22, 2023 represent shares sold to cover the reporting person's tax obligations when restricted stock units belonging to the reporting person were settled. Table II does not include shares that were "net settled" by the Issuer in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units previously granted to the reporting person.
09/21/2023
02/17/2022
/s/ Rakhi Kumar